A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Institut Bergonié
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Barbara Ann Karmanos Cancer Institute
University of Kentucky
Washington University School of Medicine
Stanford University
Amgen
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Amgen
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Altor BioScience
National Institutes of Health Clinical Center (CC)